These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 16022633

  • 41. Heterogeneity of colony stimulating factor-1 gene expression in the skeleton of four osteopetrotic mutations in rats and mice.
    Shalhoub V, Jackson ME, Paradise C, Stein GS, Lian JB, Marks SC.
    J Cell Physiol; 1996 Feb; 166(2):340-50. PubMed ID: 8591994
    [Abstract] [Full Text] [Related]

  • 42. Gene expression during skeletal development in three osteopetrotic rat mutations. Evidence for osteoblast abnormalities.
    Shalhoub V, Jackson ME, Lian JB, Stein GS, Marks SC.
    J Biol Chem; 1991 May 25; 266(15):9847-56. PubMed ID: 2033073
    [Abstract] [Full Text] [Related]

  • 43. Morphological evidence of reduced bone resorption in osteopetrotic (op) mice.
    Marks SC.
    Am J Anat; 1982 Feb 25; 163(2):157-67. PubMed ID: 7072615
    [Abstract] [Full Text] [Related]

  • 44. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations.
    Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN.
    Bone; 1995 Jun 25; 16(6):657-62. PubMed ID: 7669443
    [Abstract] [Full Text] [Related]

  • 45. Ostm1 from Mouse to Human: Insights into Osteoclast Maturation.
    Vacher J, Bruccoleri M, Pata M.
    Int J Mol Sci; 2020 Aug 05; 21(16):. PubMed ID: 32764302
    [Abstract] [Full Text] [Related]

  • 46. Defective osteoclast differentiation and function in the osteopetrotic (os) rabbit.
    Lenhard S, Popoff SN, Marks SC.
    Am J Anat; 1990 Aug 05; 188(4):438-44. PubMed ID: 2393000
    [Abstract] [Full Text] [Related]

  • 47. Mechanical properties in long bones of rat osteopetrotic mutations.
    Jämsä T, Rho JY, Fan Z, MacKay CA, Marks SC, Tuukkanen J.
    J Biomech; 2002 Feb 05; 35(2):161-5. PubMed ID: 11784534
    [Abstract] [Full Text] [Related]

  • 48. The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.
    Wada T, Nakashima T, Oliveira-dos-Santos AJ, Gasser J, Hara H, Schett G, Penninger JM.
    Nat Med; 2005 Apr 05; 11(4):394-9. PubMed ID: 15750601
    [Abstract] [Full Text] [Related]

  • 49. Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice.
    Alam I, Gerard-O'Riley RL, Acton D, Hardman SL, Hong JM, Bruzzaniti A, Econs MJ.
    Bone; 2021 Dec 05; 153():116160. PubMed ID: 34464779
    [Abstract] [Full Text] [Related]

  • 50. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.
    Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL.
    Nature; 1997 Mar 06; 386(6620):81-4. PubMed ID: 9052784
    [Abstract] [Full Text] [Related]

  • 51. Reduced life span of the osteoclast in osteopetrotic (mi and midi) mice.
    Marshall MJ, Rees JA, Nisbet NW, Wiseman J.
    Bone Miner; 1987 Apr 06; 2(2):115-24. PubMed ID: 3504723
    [Abstract] [Full Text] [Related]

  • 52. Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis.
    Flanagan AM, Sarma U, Steward CG, Vellodi A, Horton MA.
    J Bone Miner Res; 2000 Feb 06; 15(2):352-60. PubMed ID: 10703938
    [Abstract] [Full Text] [Related]

  • 53. Use of bone cell cultures to study skeletal pathology.
    Jackson ME, Sundquist KT, Marks SC.
    Microsc Res Tech; 1996 Feb 01; 33(2):232-9. PubMed ID: 8845521
    [Abstract] [Full Text] [Related]

  • 54. A quantitative histologic study of avian osteopetrotic bone demonstrating normal osteoclast numbers and increased osteoblastic activity.
    Schmidt EV, Crapo JD, Harrelson JM, Smith RE.
    Lab Invest; 1981 Feb 01; 44(2):164-73. PubMed ID: 7464041
    [Abstract] [Full Text] [Related]

  • 55. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells.
    Xian X, Moraghebi R, Löfvall H, Fasth A, Henriksen K, Richter J, Woods NB, Moscatelli I.
    Stem Cell Res Ther; 2020 May 15; 11(1):179. PubMed ID: 32414402
    [Abstract] [Full Text] [Related]

  • 56. The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors.
    Marks SC, Walker DG.
    Am J Anat; 1981 May 15; 161(1):1-10. PubMed ID: 6264778
    [Abstract] [Full Text] [Related]

  • 57. The origin of osteoclasts.
    Loutit JF, Nisbet NW.
    Immunobiology; 1982 Apr 15; 161(3-4):193-203. PubMed ID: 7047369
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Genetic basis for skeletal disease. Molecular advances in sclerosing bone disorders].
    Michigami T.
    Clin Calcium; 2010 Aug 15; 20(8):1196-202. PubMed ID: 20675930
    [Abstract] [Full Text] [Related]

  • 60. Severe developmental bone phenotype in ClC-7 deficient mice.
    Neutzsky-Wulff AV, Sims NA, Supanchart C, Kornak U, Felsenberg D, Poulton IJ, Martin TJ, Karsdal MA, Henriksen K.
    Dev Biol; 2010 Aug 15; 344(2):1001-10. PubMed ID: 20599900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.